Nebula Research & Development LLC Spring Works Therapeutics, Inc. Call Options Transaction History
Nebula Research & Development LLC
- $618 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SWTX
# of Institutions
220Shares Held
67.3MCall Options Held
64.7KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA6.54MShares$199 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$171 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.7MShares$113 Million4.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.6MShares$110 Million0.02% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$104 Million7.16% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $1.9B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...